Home / Treatments / Elect Bone Stim

Elect Bone Stim denials: what the review data shows

Independent reviewers have decided 56 published cases where an insurer denied Elect Bone Stim — and they overturned the insurer 33.9% of the time. A denial for Elect Bone Stim is a starting position, not a final answer.

Published decisions
56
2001–2026
Overturned
33.9%
19 denials reversed

Conditions behind elect bone stim denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Fracture12
25%
Bone Fracture Break9
22.2%
Stroke CVA5
40%
Vertebral Disc Prob3
0%
Back Pain3
33.3%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
34
26.5%
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
22
45.5%
Typical time to a decision
20 days
Most land between 11 and 21 days
Handled as urgent
23.2%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Physician 1: The patient is a 64-year-old woman who sustained a clavicle fracture in May 2004. At the time the patient was evaluated by an orthopedist union was not yet established and osteopenia was noted. A bone growth stimulator was recommended. The Health Plan indicates a bone growth stimulator is considered investigational for treatment of patients such as this patient. Bone growth stimulators are of proven efficacy and have been used with great success over the past twenty years. As the patient’s provider indicates, the only other treatment option for this patient who was at eight weeks from date of injury with no obvious callus formation or union, would have been surgery, plating and bone grafting of the fracture. Use of a bone growth stimulator was medically appropriate and necessary to attempt union of the patient’s fracture.
Experimental/Investigational · 2005 · IMR EI05-4150
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for RT300 SLSA functional electrical stimulator (FES). In this case, the patient has a diagnosis of locked-in state. Emphasizing the need for significant multidisciplinary rehabilitation, Researchers report that multimodal treatments that are frequent and sensory can provide significant improvement for patients with locked-in syndrome. The authors further note that FES has been found to be particularly beneficial. Researchers explain that locked-in syndrome is a rare condition that results in tetraplegia and that although acute management is much like that of any severe stroke, rehabilitation and recovery of these patients have not been previously described. Because locked-in syndrome is so rare, there is a lack of high quality studies that examine the efficacy of various treatments.
Experimental/Investigational · 2022 · IMR EI22-37444

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for an ultrasonic bone stimulator. Fowler and Hughes state, “Scaphoid fractures are the most common carpal bone fracture, usually occurring in young men, although the incidence in women has increased over the past decade. Snuffbox tenderness and/or pain with axial loading of the thumb should be treated as a scaphoid fracture until proved otherwise and the diagnosis confirmed with serial radiographs and/or advanced imaging. Nearly all displaced scaphoid fractures should undergo operative intervention to reduce the risk of nonunion. Nondisplaced fractures have high union rates with cast treatment, but require extended periods of immobilization.
Medical Necessity · 2022 · IMR MN22-36832
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for a Functional Neuromuscular Electrical Stimulating Ergometer (The RT300 FES Therapy System).Findings: Two out of three physician reviewers found that the requested Functional Neuromuscular Electrical Stimulating Ergometer (The RT300 FES Therapy System) is not likely to be more beneficial than any other available standard therapy for the patient’s condition.In a systematic review and meta-analysis, Eraifej and colleagues evaluated the effectiveness of post-stroke upper limb functional electrical stimulation (FES) on activities of daily living (ADL) and motor outcomes. A systematic review of randomised controlled trials (RCTs) was carried out.
Experimental/Investigational · 2020 · IMR EI20-33926

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Elect Bone Stimwhen you appeal: reviewers routinely find that denials like yours didn’t hold up.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Elect Bone Stim? 33.9% got it reversed.

Explain my denial — freeStart my appeal · $39